Panel: Boston 2026 and the Next Biotech Cycle: Innovation, Talent, and Competitive Advantage
Tue, May 12
|
04:50 PM - 05:30 PM
Session details:
Boston remains a global biotech hub, but the next cycle will be defined by different winners. This capstone looks at what is changing in capital markets, how talent and infrastructure are shifting, and why regional ecosystems will compete more directly for programs and manufacturing.
Key discussion points:
• What role Boston ecosystem is playing in accelerating global innovation
• Signals of IPO and funding reactivation and what investors want now
• How academic-industry collaboration is evolving
• What policy, permitting, and workforce constraints could limit growth
